Filter during dialysis or ECMO for severe illness
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a special filter (HA380 column) used during dialysis or ECMO to remove harmful substances from the blood. It is for critically ill patients with severe infection, injury, or breathing problems who also need kidney or lung support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You or a family member has given consent for you to be in the study.
- You have been diagnosed with sepsis, a major injury, acute respiratory distress, or have had major surgery.
- You need kidney dialysis or ECMO (a heart-lung machine) for support.
- You are on medicines to raise your blood pressure or help your heart pump within the first 3 days of needing this support.
- You have high levels of inflammation (CRP >100) or high lactic acid (lactate >2) in your blood.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specific type of blood-filter treatment in critically ill ICU patients who have acute kidney injury and/or failure of other organs. It aims to see whether these filters can improve care by supporting kidney function and/or calming harmful inflammation.
This study looks at an add-on blood-filter treatment used in the ICU to help remove harmful substances like waste products, inflammation signals, or toxins from the blood. Results may help doctors understand whether this approach improves care and how it should be used.
This trial tests a special device that filters parts of the blood to calm inflammation in people with severe acute kidney injury in the ICU. It may help improve recovery and reduce complications by “deactivating” certain immune cells.
This study compares two ways of giving kidney dialysis to patients who are on a heart-lung bypass machine (ECMO). It aims to find which method works better for filtering the blood.
This trial compares two different timeframes for changing filters during a critical kidney support treatment (CRRT) used when kidneys suddenly fail in hospitalized patients. The goal is to understand which filter-change schedule works better and reduces complications.
This trial tests whether a special type of dialysis filter (oXiris) helps reduce blood clotting problems in patients with septic shock and kidney failure. It may offer a better option for those needing kidney support in the ICU.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.